These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14761201

  • 1. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.
    Marhefka CA, Gao W, Chung K, Kim J, He Y, Yin D, Bohl C, Dalton JT, Miller DD.
    J Med Chem; 2004 Feb 12; 47(4):993-8. PubMed ID: 14761201
    [Abstract] [Full Text] [Related]

  • 2. Discovery of diarylhydantoins as new selective androgen receptor modulators.
    Nique F, Hebbe S, Peixoto C, Annoot D, Lefrançois JM, Duval E, Michoux L, Triballeau N, Lemoullec JM, Mollat P, Thauvin M, Prangé T, Minet D, Clément-Lacroix P, Robin-Jagerschmidt C, Fleury D, Guédin D, Deprez P.
    J Med Chem; 2012 Oct 11; 55(19):8225-35. PubMed ID: 22897611
    [Abstract] [Full Text] [Related]

  • 3. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI, Arienti KL, López FJ, Mani NS, Mais DE, Caferro TR, Long YO, Jones TK, Edwards JP, Zhi L, Schrader WT, Negro-Vilar A, Marschke KB.
    J Med Chem; 2007 May 17; 50(10):2486-96. PubMed ID: 17439112
    [Abstract] [Full Text] [Related]

  • 4. Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.
    Narayanan R, Coss CC, Yepuru M, Kearbey JD, Miller DD, Dalton JT.
    Mol Endocrinol; 2008 Nov 17; 22(11):2448-65. PubMed ID: 18801930
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
    Chen J, Hwang DJ, Chung K, Bohl CE, Fisher SJ, Miller DD, Dalton JT.
    Endocrinology; 2005 Dec 17; 146(12):5444-54. PubMed ID: 16166218
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X, Li X, Allan GF, Sbriscia T, Linton O, Lundeen SG, Sui Z.
    J Med Chem; 2007 Aug 09; 50(16):3857-69. PubMed ID: 17636947
    [Abstract] [Full Text] [Related]

  • 7. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.
    Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD.
    J Med Chem; 2009 Jun 25; 52(12):3597-617. PubMed ID: 19432422
    [No Abstract] [Full Text] [Related]

  • 8. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
    Jones A, Hwang DJ, Duke CB, He Y, Siddam A, Miller DD, Dalton JT.
    J Pharmacol Exp Ther; 2010 Aug 25; 334(2):439-48. PubMed ID: 20444881
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacodynamics of selective androgen receptor modulators.
    Yin D, Gao W, Kearbey JD, Xu H, Chung K, He Y, Marhefka CA, Veverka KA, Miller DD, Dalton JT.
    J Pharmacol Exp Ther; 2003 Mar 25; 304(3):1334-40. PubMed ID: 12604714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B.
    Toxicol Sci; 2005 Jan 25; 83(1):136-48. PubMed ID: 15483189
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators.
    Kim J, Wu D, Hwang DJ, Miller DD, Dalton JT.
    J Pharmacol Exp Ther; 2005 Oct 25; 315(1):230-9. PubMed ID: 15987833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.